NURG 633 Pharm module 4 |50 Quizees

NURG 633 Pharm module 4 |50 Quizees



1. What contributes to the development of antibiotic resistance?
A) Vaccination
B) Overuse of broad-spectrum antibiotics
C) Narrow-spectrum antibiotics
D) Improved sanitation: Overuse of broad-spectrum antibiotics
2. What is the primary goal of definitive therapy?
A) To use broad-spectrum antibiotics
B) To treat symptoms
C) To target the specific microbe causing the infection
D) To avoid culture testing: To target the specific microbe causing the infection
3. What should be done before starting antibiotic therapy?
A) Administer the antibiotic
B) Collect specimens for culture
C) Treat empirically
D) Wait for symptoms to worsen: Collect specimens for culture
4. Which antibiotic class inhibits the biosynthesis of the bacterial cell wall?
A) Aminoglycosides
B) Fluoroquinolones
C) Beta-lactams
D) Macrolides: Beta-lactams
5. Amoxicillin is first-line treatment for which of the following conditions?
A) Complicated skin infections
B) Acute otitis media (AOM)
C) Vancomycin-resistant infections
D) Chronic bacterial prostatitis
E) Sinusitis: Acute otitis media and sinusitis
6. What is a common adverse reaction associated with penicillin?
A) Liver toxicity
B) Ototoxicity
C) Immediate allergic reactions
D) Renal failure: Immediate allergic reactions
1/
13

, NURG 633 Pharm module 4 |50 Quizees

7. Which drug is commonly combined with beta-lactamase inhibitors?
A) Ceftriaxone
B) Amoxicillin
C) Clindamycin
D) Doxycycline: Amoxicillin
8. Cephalosporins are structurally similar to which class of antibiotics?
A) Aminoglycosides
B) Tetracyclines




2/
13